Appraisal of the PAM cell effect as a diagnostic test for multiple sclerosis.
The selective reduction of PAM cell yield reported by Carp and associates in the presence of tissue from patients with multiple sclerosis (MS) has been attributed to replication in culture of a viral agent associated with MS (MSAA). We investigated the diagnostic potential of the PAM cell effect in MS and in optic neuritis (ON). Six serum and 7 CSF samples from 7 patients with MS, 3 serum and 3 CSF samples from 4 patients with idiopathic ON, and 4 sera from 4 patients with ON induced by ethambutal toxicity were tested. Blind counting showed no reduction in PAM cell yield in the MS group nor any significant difference between the two ON groups. Disturbing inconsistencies in PAM cell growth rates over time and between control flasks were demonstrated.
D002478:Cells, Cultured; D003937:Diagnosis, Differential; D004977:Ethambutol / Q000009:adverse effects; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis*; D009902:Optic Neuritis / Q000139:chemically induced / Q000175:diagnosis*
D004977:Ethambutol